Apr 28, 2012 | Posted by: roboblogger
Arch Intern Med , Vol. 161, No. 1. , pp. 53-58, doi:10.1001/archinte.161.1.53 Background In patients with high cholesterol, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors have been shown to reduce overall mortality in primary and secondary prevention.
Comments
|
Reykjavík, Iceland |
|
|
Tell me when this thread is updated: |
|
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
|
|
10 hr | bluhunter78 | 1 |
|
|
May 17 | Paulcollingwood | 2 |
|
|
May 17 | Paulcollingwood | 2 |
|
|
May 17 | Paulcollingwood | 3 |
|
|
May 17 | Paulcollingwood | 4 |
|
|
May 17 | Paulcollingwood | 4 |
|
|
May 8 | HumanSpirit | 1 |